Precipio, Inc. (PRPO): Price and Financial Metrics

Precipio, Inc. (PRPO): $2.98

0.06 (+2.05%)

POWR Rating

Component Grades













Add PRPO to Watchlist
Sign Up

Industry: Biotech


of 505

in industry


  • Growth is the dimension where PRPO ranks best; there it ranks ahead of 64.27% of US stocks.
  • The strongest trend for PRPO is in Sentiment, which has been heading up over the past 34 weeks.
  • PRPO ranks lowest in Stability; there it ranks in the 6th percentile.

PRPO Stock Summary

  • PRPO has a higher market value than merely 9.36% of US stocks; more precisely, its current market capitalization is $67,443,330.
  • As for revenue growth, note that PRPO's revenue has grown 93.59% over the past 12 months; that beats the revenue growth of 93.02% of US companies in our set.
  • Precipio Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -33.81%, greater than the shareholder yield of only 8.48% of stocks in our set.
  • Stocks that are quantitatively similar to PRPO, based on their financial statements, market capitalization, and price volatility, are RGR, CURI, DGLY, MPX, and AMSF.
  • PRPO's SEC filings can be seen here. And to visit Precipio Inc's official web site, go to

PRPO Valuation Summary

  • PRPO's EV/EBIT ratio is -6.4; this is 121.84% lower than that of the median Healthcare stock.
  • PRPO's price/sales ratio has moved up 2.4 over the prior 243 months.
  • Over the past 243 months, PRPO's price/earnings ratio has gone up 36.2.

Below are key valuation metrics over time for PRPO.

Stock Date P/S P/B P/E EV/EBIT
PRPO 2021-08-31 9.9 2.8 -7.9 -6.4
PRPO 2021-08-30 9.6 2.7 -7.7 -6.2
PRPO 2021-08-27 9.6 2.7 -7.7 -6.2
PRPO 2021-08-26 10.7 3.0 -8.6 -7.0
PRPO 2021-08-25 10.1 2.9 -8.1 -6.6
PRPO 2021-08-24 9.4 2.7 -7.5 -6.0

PRPO Growth Metrics

  • Its 4 year price growth rate is now at -99.75%.
  • Its 3 year net income to common stockholders growth rate is now at 54.33%.
  • Its 2 year net cashflow from operations growth rate is now at -13.69%.
PRPO's revenue has moved down $17,473,000 over the prior 70 months.

The table below shows PRPO's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 7.736 -6.92 -9.636
2021-03-31 6.7 -7.134 -8.872
2020-12-31 6.092 -7.434 -13.969
2020-09-30 4.839 -8.123 -15.881
2020-06-30 3.996 -7.816 -14.476
2020-03-31 3.63 -8.851 -18.14

PRPO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • PRPO has a Quality Grade of D, ranking ahead of 6.89% of graded US stocks.
  • PRPO's asset turnover comes in at 0.324 -- ranking 57th of 75 Measuring and Control Equipment stocks.
  • AXDX, TMO, and PACB are the stocks whose asset turnover ratios are most correlated with PRPO.

The table below shows PRPO's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.324 0.268 19.897
2021-03-31 0.331 0.223 15.583
2020-12-31 0.307 0.189 14.223
2020-09-30 0.247 0.135 15.678
2020-06-30 0.200 0.076 11.555
2020-03-31 0.174 0.084 12.523

PRPO Price Target

For more insight on analysts targets of PRPO, see our PRPO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $7.00 Average Broker Recommendation 1.5 (Moderate Buy)

PRPO Stock Price Chart Interactive Chart >

Price chart for PRPO

PRPO Price/Volume Stats

Current price $2.98 52-week high $9.18
Prev. close $2.92 52-week low $1.72
Day low $2.90 Volume 345,000
Day high $3.09 Avg. volume 5,537,994
50-day MA $3.11 Dividend yield N/A
200-day MA $2.96 Market Cap 67.67M

Precipio, Inc. (PRPO) Company Bio

Precipio, Inc. operates as a biotechnology company. The Company offers medicines for oncology, cardiology, neurology, and inherited diseases. Precipio also provides specialized clinical and research services to biopharmaceutical companies developing targeted therapies. Precipio serves customers in the United States.

PRPO Latest News Stream

Event/Time News Detail
Loading, please wait...

PRPO Latest Social Stream

Loading social stream, please wait...

View Full PRPO Social Stream

Latest PRPO News From Around the Web

Below are the latest news stories about Precipio Inc that investors may wish to consider to help them evaluate PRPO as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

The weekend is officially over and that means it's time to jump back into investing with a look at Monday's biggest pre-market stock movers!

William White on InvestorPlace | August 30, 2021

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Good morning, trader!

William White on InvestorPlace | August 27, 2021

American Oncology Network Partners with Precipio to Bring HemeScreen® into AON’s Laboratory

HemeScreen Assays will enable AON to deliver rapid patient diagnostics for hematologic malignancies through advanced molecular screening technologyNEW HAVEN, Conn. and FORT MYERS, Fla., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), and American Oncology Network, LLC (AON), a high-growth community oncology provider, announces the signing of an agreement under which AON will adopt Precipio’s HemeScreen® technology and begin running HemeScreen

Yahoo | August 26, 2021

Precipio Reschedules Q2-2021 Shareholder Update Call

Due to a schedule conflict, the call is moved to Thursday August 26th at 5:00PM ESTNEW HAVEN, Conn., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be rescheduling its Q2-2021 update call from Monday August 23rd to Thursday, August 26th at 5:00 PM ET due to a schedule conflict. The conference call may be accessed by calling 844-695-5519 (international callers dial 1-412-902-6760). All callers should ask for the Precipio Inc. conference

Yahoo | August 20, 2021

Precipio Corrects Announcement of Q2-2021 Shareholder Update Call

(Reference to “year-end” was included incorrectly)NEW HAVEN, Conn., Aug. 13, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2021 update call on Monday, August 23rd at 5:00 PM ET. The call will include discussions on all of the company’s core businesses. The shareholder communication issued yesterday, August 12th, inadvertently referenced “year-end” in lieu of “Q2-2021 Company Update”. We wish to inform you of this misstatement,

Yahoo | August 13, 2021

Read More 'PRPO' Stories Here

PRPO Price Returns

1-mo -8.87%
3-mo -17.91%
6-mo 27.90%
1-year 25.74%
3-year -49.70%
5-year -97.72%
YTD 43.96%
2020 0.98%
2019 -8.89%
2018 -87.50%
2017 -85.71%
2016 -73.83%

Continue Researching PRPO

Want to see what other sources are saying about Precipio Inc's financials and stock price? Try the links below:

Precipio Inc (PRPO) Stock Price | Nasdaq
Precipio Inc (PRPO) Stock Quote, History and News - Yahoo Finance
Precipio Inc (PRPO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7839 seconds.